We are live on ! Find out more
YTEN

Yield10 Bioscience, Inc. Common Stock
YTEN

Delisted

YTEN was delisted on the 15th of May, 2024.

Back to rankings

16 hedge funds and large institutions have $11.9M invested in Yield10 Bioscience, Inc. Common Stock in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 16 → 16 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

12% less capital invested

Capital invested by funds: $13.5M → $11.9M (-$1.58M)

Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
MCM
McRae Capital Management
New Jersey
+$80.5K

Top Sellers

Rank Fund Capital Flow
1
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$49K
2
Jane Street
Jane Street
New York
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$3.61M – – –
State Farm Mutual Automobile Insurance
2
State Farm Mutual Automobile Insurance
Illinois
$2.9M – – –
OIM
3
Oracle Investment Management
Connecticut
$2.09M – – –
BIT
4
BlackRock Institutional Trust
California
$753K – – –
Vanguard Group
5
Vanguard Group
Pennsylvania
$603K – – –
FA
6
FCG Advisors
New Jersey
$543K – – –
GC
7
GMT Capital
Georgia
$255K – – –
BCM
8
Bridgeway Capital Management
Texas
$201K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$164K – – –
AG
10
Aperio Group
California
$105K – – –
Northern Trust
11
Northern Trust
Illinois
$80K – – –
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$79K – – –
MCM
13
McRae Capital Management
New Jersey
$74K +$80.5K +1 New
Renaissance Technologies
14
Renaissance Technologies
New York
$63K – – –
Bank of New York Mellon
15
Bank of New York Mellon
New York
$61K – – –
Morgan Stanley
16
Morgan Stanley
New York
$59K – – –
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$29K – – –
JG
18
Jefferies Group
New York
$25K – – –
Dimensional Fund Advisors
19
Dimensional Fund Advisors
Texas
$24K – – –
State Street
20
State Street
Massachusetts
$23K – – –
Citigroup
21
Citigroup
New York
$19K – – –
William Blair & Company
22
William Blair & Company
Illinois
$16K – – –
HC
23
Highmount Capital
New York
$15K – – –
Deutsche Bank
24
Deutsche Bank
Germany
$14K – – –
GC
25
Guggenheim Capital
Illinois
$14K – – –
1
2

YTEN Hedge Fund Activity: Q3 2013 in Review

16 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q3 2013, worth a combined $11.9M — down 12% from $13.5M a quarter earlier.

Fund positioning in YTEN was balanced in Q3 2013: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 0 trimmed.

The largest buyer was McRae Capital Management, opening a new position worth an estimated $80.5K. The largest seller was Jacobs Levy Equity Management, exiting entirely with an estimated $49K sold.

  • 16 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q3 2013, unchanged from Q2 2013.
  • Funds reported $11.9M of Yield10 Bioscience, Inc. Common Stock stock for Q3 2013, down 12% quarter-over-quarter.
  • 1 fund opened new Yield10 Bioscience, Inc. Common Stock positions in Q3 2013 and 1 closed out, a net change of 0 holders.
  • The largest Yield10 Bioscience, Inc. Common Stock buyer in Q3 2013 was McRae Capital Management, an estimated $80.5K added.
  • The largest Yield10 Bioscience, Inc. Common Stock seller in Q3 2013 was Jacobs Levy Equity Management, an estimated $49K sold.

Based on aggregated 13F filings for Q3 2013.